CCDRD: Clinical Research Excellence
- 35 years experience in clinical drug development
- Comprehensive solutions for Phase I-IV clinical trials
- Scientific advice support with European authorities, EMA, and FDA
- Headquarters near Berlin with operations in 10 Central and Eastern European countries
- Strategic infrastructure throughout Central and Eastern Europe
- Portfolio of ~1200 Phase I trials and 150 clinical endpoint studies
- EMA and FDA-inspected Phase I units in Bulgaria and Türkiye (90 beds)
- Strong investigator networks across all operational regions
- Specialized expertise in complex drug delivery systems:
- Orally inhaled products (80+ BE studies)
- Depot injectables and implants
- Transdermal systems
- Dermatologicals
- Ophthalmologicals
- Therapeutic expertise across 15+ indications (oncology, CNS, respiratory)
- Integrated services from study design to final reporting
- Unique geographical footprint in EEA and non-EEA regions
- Excellence in technically challenging studies
Address
Hoppegarten
Brandenburg
Germany
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}